Stilla Technologies

In the Molecular Pathology department of the Dijon University Hospital, liquid biopsy analyses were set up since March 2016. Here we present the implementation of the 3-color Crystal Digital PCR system in our laboratory for the management of melanoma and lung cancer patients under targeted therapy.

Learning outcomes:
- Gain a better understanding of the liquid biopsy process for metastatic melanoma and lung cancer patients
- Understand the Naica System workflow and its advantages
- Learn the benefits of digital PCR for the detection of circulating tumor DNA, circulating tumor cells, and circulating tumor exosomes in liquid biopsy
- Understand the advantages of digital PCR for monitoring patients and their treatment

about 1 month ago